P1,P5-Di(adenosine-5") pentaphosphate pentaammonium salt

Santa Cruz Biotechnology, Inc

Revision date : 2010-12-22

SDS Library

Move your SDS library online today

Check Icon
Setup – Easy setup with our database of 16 million+ SDSs
Check Icon
Up-to-date – Your SDS get updated to latest versions.
Check Icon
Employee access – Tablets, Smartphones, or link from Corporate Intranet
Check Icon
Safety – One-click access to first aid information.
Check Icon
Labels – Generate Secondary Container Labels with just one click.
Health risk rating
Safety risk rating
Environmental risk rating

General Information

Revision date

2010-12-22

Product name

P1,P5-Di(adenosine-5") pentaphosphate pentaammonium salt

CAS No.

102783-61-9

supplier name

Santa Cruz Biotechnology, Inc

Emergency telephone

+613 9573 3112

Icons in SDS

M004 M009 M010 M011 M022 M026

Company Information

company name

Santa Cruz Biotechnology, Inc

Section 2

SECTION 2: Hazards identification

CHEMWATCH HAZARD RATINGS Min Max Flammability: 1 Toxicity: 2 Body Contact: 0 Min/Nil=0 Low=1 Reactivity: 1 Moderate=2 High=3 Chronic: 0 Extreme=4 CANADIAN WHMIS SYMBOLS None EMERGENCY OVERVIEW RISK

Potential Acute Health Effects

SWALLOWED Although ingestion is not thought to produce harmful effects, the material may still be damaging to the health of the individual following ingestion, especially where pre-existing organ (e.g. liver, kidney) damage is evident. Accidental ingestion of the material may be damaging to the health of the individual. Large doses of ammonia or injected ammonium salts may produce diarrhea and may be sufficiently absorbed to produce increased production of urine and systemic poisoning. Symptoms include weakening of facial muscle, tremor, anxiety, reduced muscle and limb control. Adenosine has a depressant action in the brain, heart, kidneys and other organs and is believed to mediate its effects via four adenosine receptor subtypes (A1, A2a, A2b, and A3). In addition, adenosine has been shown to be involved in pain cognition, movement and sleep. Caffeine and other alkylxanthines act as physiological stimulants by blocking the neuromodulator effects of adenosine. Adenosine receptor agonists, which are almost exclusively derivatives of adenosine have been identified as potential anti-arrhythmic, anti- lipolytic (thus antidiabetic) and neuroprotective agents (as agonists of the A1 receptor) and hypotensive and antipsychotic agents (as agonists of the A2a receptor). A3 receptor agonists have potential as prophylactic neuroprotective agents. The release of inflammatory mediators from mast cells, in response to A3 receptor activation, is proposed as the origin of the resultant hypotensive effect. There is substantial impetus for the development of therapeutic agents based on selective interactions with one of the four subtypes of receptor. In brain, exogenously administered adenosine receptor agonists are efficient in producing neuroprotection. Neuroprotection is, in part, due to counteraction of the damaging effects of excessive glutamine release. Adenosine receptors have also been proposed to play a role in the patho-physiology of cerebral ischaemia. Adenosine receptors are members of the G protein-coupled receptor family and possess seven transmembrane helical regions. Extracellular adenosine, produced locally in response to increased activity or stress, activates adenosine receptors of the A1 and A2a subtypes. The A2b subtype has a considerably higher threshold for activation by endogenous adenosine. Such feedback mechanisms allow the organ to compensate for the increased activity or stress by decreasing energy demand, a feedback generally associated with A1 receptor activation, and by increasing oxygen demand (e.g. by vasodilation and inhibition of platelet and neutrophil function), a feedback generally associated with A2 receptor activation. The A3 receptor subtype requires relatively high pathological concentrations of adenosine for activation. EYE Although the material is not thought to be an irritant, direct contact with the eye may cause transient discomfort characterized by tearing or conjunctival redness (as with windburn). Slight abrasive damage may also result. SKIN The material is not thought to produce adverse health effects or skin irritation following contact (as classified using animal models). Nevertheless, good hygiene practice requires that exposure be kept to a minimum and that suitable gloves be used in an occupational setting. Open cuts, abraded or irritated skin should not be exposed to this material. Entry into the blood-stream, through, for example, cuts, abrasions or lesions, may produce systemic injury with harmful effects. Examine the skin prior to the use of the material and ensure that any external damage is suitably protected. INHALED The material is not thought to produce either adverse health effects or irritation of the respiratory tract following inhalation (as classified using animal models). Nevertheless, adverse effects have been produced following exposure of animals by at least one other route and good hygiene practice requires that exposure be kept to a minimum and that suitable control measures be used in an occupational setting. Persons with impaired respiratory function, airway diseases and conditions such as emphysema or chronic bronchitis, may incur further disability if excessive concentrations of particulate are inhaled.

Potential chronic health

Long-term exposure to the product is not thought to produce chronic effects adverse to the health (as classified using animal models); nevertheless exposure by all routes should be minimized as a matter of course. Long term exposure to high dust concentrations may cause changes in lung function i.e. pneumoconiosis; caused by particles less than 0.5 micron penetrating and remaining in the lung.

SDS Library

Move your SDS library online today

Check Icon
Setup – Easy setup with our database of 16 million+ SDSs
Check Icon
Up-to-date – Your SDS get updated to latest versions.
Check Icon
Employee access – Tablets, Smartphones, or link from Corporate Intranet
Check Icon
Safety – One-click access to first aid information.
Check Icon
Labels – Generate Secondary Container Labels with just one click.